Safe COVID-19 vaccines for Europeans
A safe and effective vaccine is our best chance to beat coronavirus and return to our normal lives.
The European Commission has been working tirelessly to secure doses of potential vaccines, that can be shared with all.
12 January 2021 – The European Commission concludes exploratory talks with Valneva to secure a new potential vaccine
The Commission has concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19 once proven safe and effective. The envisaged contract would provide for the possibility for all EU Member States to purchase 30 million doses, with an option to purchase up to 30 million more doses.All highlights
Areas of the Commission’s response